Tpg Gp A, LLC Allogene Therapeutics, Inc. Transaction History
Tpg Gp A, LLC
- $4.02 Billion
- Q2 2024
A detailed history of Tpg Gp A, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Tpg Gp A, LLC holds 18,716,306 shares of ALLO stock, worth $56.1 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
18,716,306
Previous 18,716,306
-0.0%
Holding current value
$56.1 Million
Previous $83.7 Million
47.88%
% of portfolio
1.08%
Previous 1.86%
Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
173Shares Held
132MCall Options Held
94.3KPut Options Held
112K-
Black Rock Inc. New York, NY16.4MShares$49.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$24.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.67MShares$23 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$20.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.79MShares$17.4 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $431M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...